SignatureFD’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.23M | Buy |
79,631
+12,052
| +18% | +$186K | 0.02% | 307 |
|
2025
Q1 | $1M | Buy |
67,579
+2,482
| +4% | +$36.9K | 0.02% | 342 |
|
2024
Q4 | $862K | Buy |
65,097
+19,786
| +44% | +$262K | 0.02% | 373 |
|
2024
Q3 | $644K | Buy |
45,311
+10,070
| +29% | +$143K | 0.01% | 446 |
|
2024
Q2 | $456K | Sell |
35,241
-14,900
| -30% | -$193K | 0.01% | 526 |
|
2024
Q1 | $696K | Buy |
50,141
+10,654
| +27% | +$148K | 0.01% | 416 |
|
2023
Q4 | $563K | Sell |
39,487
-3,838
| -9% | -$54.8K | 0.01% | 441 |
|
2023
Q3 | $670K | Sell |
43,325
-351
| -0.8% | -$5.43K | 0.02% | 355 |
|
2023
Q2 | $686K | Buy |
43,676
+523
| +1% | +$8.22K | 0.02% | 349 |
|
2023
Q1 | $711K | Buy |
43,153
+14,538
| +51% | +$240K | 0.02% | 325 |
|
2022
Q4 | $446K | Sell |
28,615
-6,688
| -19% | -$104K | 0.01% | 444 |
|
2022
Q3 | $458K | Buy |
35,303
+10,972
| +45% | +$142K | 0.02% | 403 |
|
2022
Q2 | $342K | Sell |
24,331
-10,720
| -31% | -$151K | 0.01% | 487 |
|
2022
Q1 | $502K | Buy |
35,051
+13,052
| +59% | +$187K | 0.02% | 401 |
|
2021
Q4 | $300K | Sell |
21,999
-1,957
| -8% | -$26.7K | 0.01% | 570 |
|
2021
Q3 | $392K | Buy |
23,956
+4,907
| +26% | +$80.3K | 0.01% | 454 |
|
2021
Q2 | $321K | Buy |
19,049
+951
| +5% | +$16K | 0.01% | 500 |
|
2021
Q1 | $330K | Buy |
18,098
+2,018
| +13% | +$36.8K | 0.01% | 421 |
|
2020
Q4 | $293K | Buy |
16,080
+1,382
| +9% | +$25.2K | 0.01% | 417 |
|
2020
Q3 | $262K | Buy |
14,698
+951
| +7% | +$17K | 0.01% | 386 |
|
2020
Q2 | $246K | Buy |
13,747
+778
| +6% | +$13.9K | 0.01% | 383 |
|
2020
Q1 | $197K | Sell |
12,969
-4,567
| -26% | -$69.4K | 0.02% | 417 |
|
2019
Q4 | $346K | Buy |
17,536
+3,351
| +24% | +$66.1K | 0.03% | 321 |
|
2019
Q3 | $244K | Buy |
14,185
+6,810
| +92% | +$117K | 0.02% | 358 |
|
2019
Q2 | $131K | Sell |
7,375
-5,831
| -44% | -$104K | 0.01% | 528 |
|
2019
Q1 | $269K | Buy |
13,206
+12,676
| +2,392% | +$258K | 0.02% | 296 |
|
2018
Q4 | $9K | Buy |
+530
| New | +$9K | ﹤0.01% | 1391 |
|